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ABSTRACT
Objective: This study in bioinformatics aims to investigate the potential effect of Ipomoea tricolor and Sophora tomentosa on liver function enzymes 
activity, serum lipid profile, oxidative stress biomarkers, and on blood glucose in high fat diet-induced hypercholesterolemia (HC) and STZ-induced 
hyperglycemia (HG) in rats.
Methods: Blood glucose level, liver function enzymes, alanine aminotransferases and aspartate aminotransferases, alkaline phosphatase, and lactate 
dehydrogenase (LDH) were determined. Besides, lipid profile including total cholesterol (TC), triacylglycerol (TG), total lipid, and high-density 
lipoprotein-cholesterol was investigated. Moreover, oxidative stress biomarkers, lipid peroxide, and nitric oxide as well as non-enzymatic antioxidant, 
glutathione (GSH) were also examined in different therapeutic groups.
Results: A significant increase in blood glucose level, liver function enzyme activities, LDH, lipid profile and oxidative stress markers, while significant 
decrease in LDH-C and GSH level in HC-HG induced rats compared to control one. A marked amelioration in all biochemical parameters under 
investigation on treatment of HC-HG rats with I. tricolor and S. tomentosa with different fluctuating percentages of improvement. Histopathological 
examination of liver and pancreas was also performed and declared HC-HG showed congestion in portal vessels and sinusoids with mild centrilobular 
hepatocyte degeneration, marked hepatocyte ballooning and hydropic degeneration, while HC-HG treated rats with I. tricolor and S. tomentosa showed 
normal lobular hepatic architecture with mild sinusoidal dilatation and congestion. On the other hand, a histological organization of pancreas of HC-HG 
rats showing disarrangement changes in pancreatic blood vessels and interlobular duct as well as disordered in acini. The treatment of HC-HG rats with 
I. tricolor and S. tomentosa showed enhancement in Langerhans cells and restore of most pancreatic tissue in comparison with standard drugs.
Conclusion: The statistical results showed that each extract ameliorated high blood glucose level liver injury, HC and oxidative stress indicating 
relieving of oxidative damage associated with the complexity of HG and HC. These results demonstrated that these two plants extracts may be a 
candidate intelligent antioxidant, hypolipidemic, hypoglycemic, and hepatoprotective nutraceuticals which need further clinical investigation to be 
applied effectively to reduce perturbation in HC associated diabetes.
Keywords: Ipomoea tricolor, Sophora tomentosa, Lipid profile and liver function enzymes, Endothelial dysfunction markers, Statistics and image 
recognition, Histopathological analysis.
INTRODUCTION
Some of recent researches in bioinformatics are done for using 
natural extracts in treating of compound and complex diseases as 
hyperlipidemia and hyperglycemia (HG) diseases [1].
Hyperlipidemia is known to be the leading risk factor for atherosclerosis. 
Abnormal increases in serum total cholesterol (TC), triacylglycerol 
(TG), and high-density lipoprotein-cholesterol (HDL-C) levels are 
among the indicators of atherosclerosis development, while elevated 
serum HDL-C is known to be protective against the development of 
atherosclerosis [2]. Oxidative stress plays a major role in the process 
of endothelial damage and atherosclerosis. Reactive oxygen species 
(ROS) can oxygenate and modify low-density lipoprotein-cholesterol 
(LDL-C) to form oxidized LDL-C, leading to the accumulation of 
cholesterol in phagocytes and to the formation of foam cells, promoting 
the development of atherosclerosis [2]. Thus, reduction in plasma 
cholesterol level could improve the endothelial cell function and reduce 
vascular inflammation [3]. The most commonly used lipid regulators 
at present are statins and fibrates. Although the statins overall safety 
profile is very good, some concerns have been raised regarding the 
nature of the side effects, i.e., rhabdomyolysis, essentially because they 
seem completely linked to the mechanism of action of this class of drugs. 
In addition, statins do not work for all patients [4]. Therefore, there is a 
need for drugs that would not target an enzymatic pathway, as statins 
do, or will not induce global changes of gene expression, as fibrates do, 
but instead directly target cholesterol present in the blood flow.
Plant phenolic compounds are important constituents known as 
natural tender drugs. Compounds other than the bioactive flavonoids 
as alkaloids, coumarochromones, saponins, triterpene glycosides, 
phospholipids, polysaccharides, oligostilbenes, and fatty acids are 
reported in many Sophora species [5]. The roots of Sophora flavescens is 
one of the bitter and cold Chinese medicines commonly used to remove 
lung heat have been used to counteract diabetes mellitus (DM) and 
exerted good clinical effects for diabetic patients in some folk hospitals 
in Fujian province [6]. Thus, this study aims to evaluate the possible 
beneficial effect of Ipomoea tricolor and Sophora tomentosa crude 
extracts on serum lipid parameters in hypercholesterolemic (HC) and 
hyperglycemic (HG) rats as well as the histological examination of the 
liver and pancreas were carried out to confirm the biochemical findings 
and also to develop and utilize effective natural lipid and blood glucose 
regulators for more aggressive treatment of HC associated with HG.
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Aerial parts of the I. tricolor Cav. (Convolvulaceae) and the S. tomentosa L. 
(Fabaceae) were collected in May 2014 from El-Qanater, Qalyubia 
Governorate. The identification of the plants material was performed by 
TreasLabib, consultant of plant taxonomy at the Ministry of Agriculture 
and ex-director of Orman Garden, Giza, Egypt. A voucher sample is kept 
in the herbarium of National Research Centre (NRC), Egypt.
Preparation of I. tricolor and S. tomentosa extracts
Each dried powdered aerial parts (500 mg) of I. tricolor and 
S. tomentosa was, separately extracted by cold percolation in ethanol 
for 24 hrs. Each extract was, separately, recovered and ethanol was 
further added to the plant material, and the extraction was continued. 
The process was repeated three times and pooled together. The extracts 
were, separately, concentrated under reduced pressure (22-26 mmHg) 
at 40°C to yield brown to greenish brown oily crude residue; 14.1 and 
23.1 g of I. tricolor and S. tomentosa, respectively. They were maintained 
in dark glass container, at (−4°C) until use.
Chemicals
All chemicals and reagents were purchased from Biodiagnostic 
Company for diagnostic and research reagents, Egypt. Reference drug 
(atorvastatin) was purchased from NOVARTIS Pharmaceuticals. ELISA 
kits were provided by Invitrogen (U.S.A.) for IL-10, Eiaab (U.S.A.) for 
both VCAM-1 and ICAM.
Induction of HC
HC was induced in rats according to the method of reference [7], 
by feeding rats high-fat diet(cholesterol), cholesterol was orally 
administrated at a dose of 30 mg/0.3 mL olive oil/1 kg animal 5 times 
a week for 12 consecutive weeks, lard fat was mixed with normal diet 
(1 kg of animal lard was added to 5 kg of normal diet), the occurrence 
of HC was determined by measuring the lipid profile (TC, LDL-C, HDL-C, 
TG), the HC rats were only used.
Induction of diabetes
Type 2 diabetes was induced by intraperitoneally injection of a single 
dose of streptozotocin (STZ) (45 mg/kg body weight dissolved in 0.01 
M citrate buffer immediately before use [8]. After injection, animals had 
free access for food, water and were given 5% glucose solution to drink 
overnight to encounter hypoglycemic shock. Animals were checked 
daily for the presence of glycosuria [9]. Animals were considered to be 
diabetic if glycosuria was present for 3 consecutive days. After 3 days 
of STZ injection fasting blood samples were obtained and blood sugar 
level was determined (≥300 mg/dL).
Routs of administration
HC rats received an oral dose of 2 mg/kg body weight dissolved in 
distilled water of the anti-HC reference drug; atorvastatin, dissolved in 
distilled water orally by gastric intubation for 4 weeks.
Experimental design
Rats
A total of 70 Male Wister rats weighing 150±10 g were provided from 
the animal house of the NRC and housed in a temperature controlled 
environment (26-29°C), in steel mesh cages on wood-chip bedding, 
with a fixed light/dark cycle for 2 weeks as an acclimatization period 
with free access to water and food ad-libitum. This study is approved 
by the Ethical Committee of the NRC, Egypt, which provided that the 
animals will not suffer at any stage of the experiment. Animals were 
randomly divided into seven equally sized groups of 10 rats each 
(n=10) as follows:
Group 1: Normal healthy control rats, Groups 2 and 3: Normal rats 
treated orally with 250 mg/kg body of crude extract of I. tricolor 
and S. tomentosa, respectively, for 30 days. Group 4: Is considered as 
diabetic group which classified as follows: Groups 5 and 6: Diabetic rats 
oral administered 250 mg/kg body weight crude methanolic extracts 
of I. tricolor and S. mentosa for 30 days, respectively. Group 7: Diabetic 
rats administered orally antidiabetic glibenclamide reference drug 
10 mg/kg body weight daily for 30 days [10] and oral dose of 2 mg/kg 
body weight of the anti-HC reference drug; atorvastatin [2].
Blood collection and tissue sampling
By the end of the experiment (4 weeks), the animals of different groups 
were fasted for 12 hrs, weighted then blood samples were collected 
from the sublingual vein, then left to coagulate at room temperature 
and centrifuged at 3000 rpm for 15 minutes. The clear, non-hemolyzed, 
and supernatant sera were quickly removed and kept at −80°C till used 
for biochemical investigations of lipid profile and liver function.
Then, animals sacrificed using diethyl ether anesthesia and liver tissue 
was rapidly excised and accurately weighed; 0.5 g from each liver 
was homogenized in 5 mL phosphate buffer using (pH 7.4) electrical 
homogenizer. The clear homogenate was used for estimation of non-
enzymatic antioxidant defense system; lipid peroxide and nitric 
oxide (NO).
Biochemical examination
Lipid profile and liver function enzymes
Serum total lipids concentration was determined according to the 
method of reference [11], serum triglycerides (TG) concentration was 
determined according to the method of Fassati and Prencipe [12], serum 
total cholesterol (TC) level was estimated according to the method of 
Allain [13], and serum HDL-C concentration was measured according 
to the method of Lopez-Virella [14]. Serum LDL-C concentration was 
determined according to the equation of Friedewald [15]. Glucose 
was determined in blood serum using colorimetric kits [16]. Alanine 
aminotransferases (ALT) and aspartate aminotransferases (AST) and 
alkaline phosphatase (ALP) enzyme activities were assayed by Reitman 
and Frankel [17] and Belfield and Goldberg [18], respectively. Lactate 
dehydrogenase (LDH) enzyme activity was measured according to 
El-Baz et al. [19].
Endothelial dysfunction markers
Liver NO was determined according to the method of Montgomery and 
Dymock [20]. Glutathione (GSH) level was assayed in liver homogenate 
according to the method of Beutler et al. [21]. Liver malondialdehyde 
(MDA) level as a lipid peroxidation marker was estimated according to 
the method of Satoh [22].
Histopathological analysis
Parts of liver and pancreas were kept in neutral buffered neutral 
formalin for 8 hours for fixation then processed in automatic processors 
and paraffin blocks were obtained. Sections of 3-5 μ thickness were 
stained using Hematoxylin and Eosin (H and E) stain to assess the 
cellular changes induced in the aorta in all treatment modalities; like 
the presence of foam cells in subintima as well as media, interruption 
of elastic lamina and presence or absence of fibrosis. The slides were 
examined and photographed under a light microscope at a magnification 
power of ×200.
Statistical analysis
Data presented as mean±standard deviation (SD), n=10. Statistical 
analysis was performed using one-way analysis of variance SPSS 
(version 7) computer program and Co-state computer program, where 
unshared letter is significant at p≤0.05.
RESULTS AND DISCUSSION
The hypoglycemic effects of I. tricolor and S. tomentosa
These results (Table 1) indicated insignificant change in glucose level 
in healthy negative control rats treated with I. tricolor and S. tomentosa 
extracts as compared to normal control rats. Blood glucose level of 
diabetic rats showed a significant increase (287.50%), as compared to 
normal control rats. The treatment of diabetic rats with I. tricolor and 
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S. tomentosa extracts declared significant increase in blood glucose level 
with the percentage of improvement 153.31%, while the percentage 
of amelioration reached to 169.76% with S. tomentosa as compared 
to standard drugs (179.57%) (Table 1). Table 2 revealed insignificant 
change in liver enzyme activities AST, ALT, and ALP as well as LDH were 
detected in healthy rats’ orally administrated I. tricolor crude extracts 
of S. tomentosa comparing to normal control rats. However, HC-HG 
rats exhibited significant increase in enzyme activities; AST, ALT, ALP 
and LDH (129.77%, 155.73%, 117.99% and 56.74%, respectively) as 
compared to normal control one.
The treatment of HC-HG rats with I. tricolor and S. tomentosa extracts 
as well as standard drugs showed insignificant change in AST and LDH 
enzyme activities as compared to normal control rats. However, ALT and 
ALP enzyme activities recorded insignificant change with the treatment 
of S. tomentosa extract, while, on treated HC-HG rats with I. tricolor and 
reference drugs showed significant increase in ALT and ALP enzyme 
activities with improvement percentages reached to 97.83% and 85.24%, 
respectively, for ALT and 85.56 and 88.45%, respectively, for ALP (Table 2).
These results show that blood glucose level is significantly increased 
in diabetic rats with percentage reached to 205.04%, as compared to 
normal rats. This may be explained on the basis of, the loss of insulin 
effect on liver leads to glycogenolysis and increase in hepatic glucose 
production. In addition, the abnormalities of triglyceride storage 
and lipolysis in insulin-sensitive tissue such as liver are considered 
as an early manifestation of conditions characterized by insulin 
resistance [23]. Moreover, diabetes induction with STZ leads to inflate 
and ultimately degenerate the Langerhans islets β-cells [24], and 
consequently, hydrogen peroxide and hydroxyl radicals are generated. 
The generation of free radicals such as hydrogen peroxide, superoxide 
anion radicals, and hydroxyl plays a key role in the cytotoxicity of 
STZ [25].
Significant reduction in serum glucose level was observed in all treated 
groups as compared to HC-HG rats, mainly by I. tricolor extract (51.72) 
followed by S. tomentosa (35.27). This glucose-lowering effect of 
extracts may be attributed to gluconeogenesis and the regulation of 
serum lipid levels. Therefore, these results-indicates the link between 
anti-HG and hypolipidemic activities of both extracts.
Plants may act on blood glucose through different mechanisms 
including facilitating insulin’s activity, acting as potential insulin-
like substances, inhibiting insulinase activity, and increasing the 
Table 1: Comparative effects of I. tricolor and S. tomentosa supplementation on blood glucose level in control and 
different therapeutic groups
Groups Parameters Glucose (mg/dL)
Negative control Mean±SD 94.25±6.13d
Negative treated with I. tricolor Mean±SD 94.73±5.53d
% Change to control 0.51
Negative treated with S. tomentosa Mean±SD 96±8.28d
% Change to control 1.85
HC-HG Mean±SD 287.5±25.00a
% Change to control 205.04
HC-HG treated with I. tricolor Mean±SD 143±7.16b
% Change to control 51.72
% of improvement 153.31
HC-HG treated with S. tomentosa Mean±SD 127.50±6.40bc
Change to control 35.27
% of improvement 169.76
HC-HG treated with glibenclamide and atorvastatin Mean±SD 118.25±8.65c
% Change to control 25.46
% of improvement 179.57
Glucose is expressed as mg/dl and α-amylase is expressed as U/l. Data presented as mean±SD, n=10. Statistical analysis is carried out using Co-state and 
SPSS computer programs (version 8), where unshared letter is significant at p≤0.05. SD: Standard deviation, HC-HG: Hypercholesterolemia-Hyperglycemia, 
S. tomentosa: Sophora tomentosa, I. tricolor: Ipomoea tricolor
Table 2: Comparative effects of I. tricolor and S. tomentosa supplementation on liver function in control and different therapeutic groups
Groups Parameters AST (U/L) ALT (U/L) ALP (U/L) LDH (U/L)
Negative control Mean±SD 98.5±2.88b 15.25±0.64c 147.25±8.77c 26875±853.911a
Negative treated with I. tricolor Mean±SD 95±5.77b 16.75±0.95c 152.5±9.57c 25725±1871.49.911a
% Change to control +3.55 +9.83 +3.56 4.27
Negative treated with S. tomentosa Mean±SD 97.83±5.34b 17.83±1.9c 142.50±10.54c 26975±1391.34a
% Change to control +0.68 +16.91 −1.18 0.37
HC-HG Mean±SD 226.33±13.05a 39.00±3.8a 321±28.72a 11625.00±1108.67b
% Change to control +129.77 +155.73 +117.99 56.74
HC-HG treated with I. tricolor Mean±SD 89.66±9.84b 24.08±3.5b 195.00±12.9b 25750±2986.07a
% Change to control −8.975 +57.90 +32.42 4.18
% of improvement 138.75 97.83 85.56 52.55
HC-HG treated with S. tomentosa Mean±SD 92.33±2.86b 18.66±0.94c 158.16±15.91c 24850±2834.90a
% Change to control −6.26 +22.36 +7.409 7.53
% of improvement 136.04 −133.37 110.58 49.20
HC-HG treated with glibenclamide 
and atorvastatin
Mean±SD 105.00±4.08b 26.00±4.32b 190.75±9.42b 24900±2404.20a
% Change to control +6.59 +204.76 +29.54 7.34
% of improvement 123.17 85.24 88.45 49.39
Liver enzyme activities and LDH are expressed in U/L. Data presented as mean±SD, n=10. Statistical analysis is carried out using Co-state and SPSS 
computer programs (version 8), where unshared letter is significant at p≤0.05. SD: Standard deviation, HC-HG: Hypercholesterolemia-Hyperglycemia, 
S. tomentosa: Sophora tomentosa, I. tricolor: Ipomoea tricolor, ALT: Alanine aminotransferases, AST: Aspartate aminotransferases, ALT: Alkaline phosphatase, 
LDH: Lactate dehydrogenase
Asian J Pharm Clin Res, Vol 9, Suppl. 3, 2016, 122-130
 Aly et al. 
125
quality and/or quantity of the β-cells in the pancreas by enhancing 
regeneration of these cells. Furthermore, the mechanism underlying 
the reported therapeutic activity may involve, at least, an improvement 
of insulin sensitivity which can lead to an increase in peripheral glucose 
utilization [26]. Another possible action site for both extracts to exert 
there hypoglycemic effect is in the gastrointestinal tract; the fiber of 
plants may also interfere with carbohydrate absorption; thus affecting 
blood glucose, by slowing the digestion of food and decreasing the 
rate of carbohydrate absorption and clearing the postprandial glucose 
load [27]. Therefore, the hypoglycemic activity of this extracts may be 
due to inhibition of hepatic glucose production and/or stimulation of 
glucose utilization by peripheral tissues, especially muscle and adipose 
tissues [28]. In addition, both extracts could also act as inhibitors of 
tubular renal glucose reabsorption.
The hepatic ameliorative effect of I. tricolor and S. tomentosa
The hepatic ameliorative effect of I. tricolor and S. tomentosa revealed 
that serum ALT, AST, and ALP enzyme activities were significantly 
elevated in high cholesterol and glucose-induced rats as compared to 
normal rats. The serum concentrations of ALT, AST, and ALP activities 
were found to determine the functionality and cellular membranes 
integrity of the liver [29,30]. The elevated enzyme activities in serum 
of HC-HG rats reflect the alterations in serum membrane integrity 
and/or permeability leak of these enzymes into the serum [31-33] ALP 
is located in the biliary duct of the liver, obstruction of this duct was 
found to elevate the level of the enzyme in the circulation [29,30]. In 
consistent with the present results [32-34], found that; the activities of 
ALT and AST tend to increase according to the exogenous cholesterol 
contents from diet and that HC state significantly stimulate ALT and 
AST enzyme activities in the serum, resulting in increased enzyme 
leakage from hepatocytes. Excessive storage of fat in the liver affects 
liver functions and increases the susceptibility to free radical attack 
in HC-HG rats resulting in liver damage. The increases in the serum 
activities of these enzymes were found to be directly proportional to the 
degree of cellular damage as described by Yadav et al. [35]. However, 
Noori et al. [31] added that the increase in aminotransferases may be 
due to the cellular damage in the liver caused by STZ-induced diabetes. 
In agreement with the present results, Ahmed et al. [29] and Munish 
and Chanchal [36] found high enzyme concentrations of ALP and 
ALT in diabetic animals. It’s well known that ALP enzyme originates 
predominately from the liver and from bone. Persistently elevated ALP 
levels in the liver may indicate chronic cholestasis or infiltrative liver 
disease. The reduction in LDH enzyme activity in the HC-HG rats In 
good agreement with El Baz et al. [19], who noticed reduction in LDH 
enzyme activity in diabetic rats due to the perturbation in membrane 
permeability leading to leakage of the enzyme to the circulation.
On the other hand, the treatment of HG-HC rats with I. tricolor and 
S. tomentosa extracts ameliorated the structural and functional integrity 
of the liver membrane and pancreas as evident by the significant 
reduction in the elevated levels of these serum marker enzymes and 
amelioration in pancreas and liver architectures in HG-HC treated rats 
as compared to the positive control rats. The declined enzyme activities 
secondary to drug and the extract treatments might be ascribed to 
their ability to maintain membrane integrity thereby restricting the 
leakage of these enzymes [37,38]. Thus, the enhancement in enzyme 
activities resulting from extracts supplementation may help in 
preventing oxidative damage by detoxifying ROS; that in turn, reduce 
hyperlipidemia. Thus, it is expected that both treatments are effective 
for the recovery of the hepatic function by restoring lipid metabolism 
that subsequently delays the hepatic disorders.
The ameliorative effects of both extracts in diabetic rats may be 
explained on the basis of Munish and Chanchal [36] study, that the 
hypoglycemic activity and the reducing effect on biochemical profile; 
ALP, AST, and ALT with certain Phyllanthus extracts on biochemical 
profile (renal, liver and cardiovascular complications) in case of 
alloxan-induced diabetic rats may be attributed to the presence of 
phenolic compounds. Most of the bioactive compounds (especially 
flavonoids and triterpenoids) showed a mechanism to improve the liver 
and pancreas cells functions and hence normalized liver enzymes [39].
Genus of Sophora and Ipomoea are a prolific source of structurally 
diverse bioactive metabolites with interesting activities [5,40]. The 
chemical review on Sophora tomentosa reveals that the presence of 
alkaloids, polysaccharides, isoprenylated flavonoids, isoflavonones, 
flavones, flavonols, their glycosides, and these compounds have been 
previously reported to have wide bioactivity including anti-diabetic, 
antioxidant, hepatoprotective and immune regulatory [5,6]. Recently, 
it was found that the ethyl acetate extract of roots of S. flavescens 
significantly controlled levels of insulin, through stimulation of GLUT4 
which attenuated by AMP-activated protein kinase pathway and this 
extract was practically non-toxic for mice.
Many phytochemical studies [40] declared that Ipomoea contains many 
bioactive secondary metabolites which having promising effects in 
ameliorating different disorders such as anti-nociceptive, anti-oxidative, 
and anti-inflammatory effects. Several phenolic compounds, namely, 
phenolic acids, flavonoids, organic acids, and anthocyanins [41,42] have 
been described in several Ipomoea species. It was reported that the 
isolated anthocyanins decreased atherosclerosis progress, ameliorated 
oxidative status and endothelial dysfunction in mice [42], and also may 
act as antioxidants [40-42].
Thus, the ameliorative effect of both extracts may be related to the 
secondary metabolites content representing in phenolic compounds 
as flavonoids, tannins, and anthocyanins. The mechanism of 
hepatoprotective and the amelioration of hepatic and pancreatic issues 
ability of extracts may be attributed to numerous bioactive compounds 
such as isoprenylated flavonoids, terpenoids, flavonoids, alkaloids, 
and polysaccharides. Hepatotoxic constituents of S. flavescens were 
determined to be prenylated flavanones, kurarinone, and sophora 
flavanone [42]. Oxymatrine, a quinolizidine alkaloid, has been 
widely used for the treatment of hepatitis. A study displayed that 
oxymatrine can alleviate HG and hyperlipemia in a high-fat diet and 
STZ-induced diabetic rats might by improving insulin secretion and 
sensitivity [43,44].
The antioxidant effect of I. tricolor and S. tomentosa
It is oblivious from Table 3 that, normal control rats treated with 
I. tricolor and S. tomentosa extracts, showed insignificant change in 
the levels of NO, GSH and MDA as compared to normal control rats. 
Diabetic rats recorded a significant increase in MDA and NO levels by 
14.65 and 23.86%, respectively. While significant reduction in GSH level 
(17.45%) was detected. The treatment of HC-HG rats with I. tricolor 
and S. tomentosa extracts as well as drugs showed significant reduction 
in GSH level with percentages of improvement 38.91%, 47.64% and 
43.86%, respectively. In addition, HC-HG rats treated with I. tricolor 
and standard drugs declared insignificant change in lipid peroxide level 
with amelioration percentages 112.37% and 113.02%, respectively. 
However, a significant increase was recorded in lipid peroxide 
level on treatment HC-HG rats with S. tomentosa with amelioration 
percentage 89.57%. Furthermore, NO showed insignificant change with 
percentages of amelioration 118.89% and 118.95%, respectively, while 
the treatment of HC-HG rats with S. tomentosa extract demonstrated 
significant increase with amelioration percent 109.14% (Table 3).
As compared to control group, HC-HG rats recorded significant decrease 
in GSH level by 56.36%. However, MDA and NO showed dramatic 
elevation of 127.03% and 142.76%, thus HC-HG induced oxidative stress 
resulted in elevation in hepatic MDA and NO, and in contrast a decline in 
hepatic GSH level, the non-enzymatic antioxidant defense system. The 
present results are in accordance to the work done by Prasad et al. [45], 
who showed that diet-induced HC and STZ-induced rats produces 
oxidative stress in the myocardium. The induced oxidative damage has 
been demonstrated by the increased lipid peroxidation and inhibition 
of enzymes required to prevent such oxidative damage and liver GSH 
concentration [45,46]. As they observed a significant elevation of 
Asian J Pharm Clin Res, Vol 9, Suppl. 3, 2016, 122-130
 Aly et al. 
126
hepatic thiobarbituric acid reactive substances concentration in rats 
fed a high cholesterol diet as compared to normal control rats.
NO at physiological levels may play an important role in the maintenance 
of vascular homeostasis, while NO produced under oxidative stress 
conditions may evoke specific tissue injury. Serum NO level may also 
increase during various pathological conditions, as inflammation, 
sepsis and stroke are associated with NO overproduction [47]. Oxygen 
radicals exert their cytotoxic effects, in part, by causing peroxidation of 
membrane lipids, which results in increased membrane permeability 
and the loss of membrane integrity. Increased cholesterol levels 
enhance the production of ROS and provoke cellular injury [48]. This 
study declared significant increase in the level of NO (142.76%) in 
the cholesterol-diabetic stressed rats in comparison to controls. This 
increase in NO level might be attributed to HC-HG induced oxidative 
stress. The results clearly showed the increasing NO level might be 
via apoptosis [49]. These results were documented by the present 
findings of hepatocyte degeneration and disarrangement changes in 
pancreatic blood vessels and interlobular duct. In good agreement with 
the present result, ElBaz et al. [50,51] declared that free radicals act 
by lipid peroxidation leads to release of MDA in a large amount. Thus, 
MDA concentration in the organs liver and plasma can inform about 
the level of cell damage and apoptosis in diabetic patients and/or 
animals, which in turn effect on the liver and pancreatic tissue showing 
marked hepatocyte ballooning and hydropic degeneration as well as 
disarrangement changes in pancreatic blood vessels and interlobular 
duct [48,50,51]. In DM, the high levels of glucose (HG) are a known 
reason for enhancing the elevated levels of plasma free radical [50,51].
GSH is one of the most abundant non-enzymatic antioxidant 
biomolecules present in tissues which can alter the diabetic effects 
via scavenging free radicals or preventing their conversion to toxic 
products or provision of a substrate for glutathione peroxidase and 
glutathione S-transferase [52-54].
I. tricolor and S. tomentosa extract treatments to stressed rats 
showed marked surge in GSH concentration with the percentage of 
improvements38.91%, 47.64% and 43.86%, respectively, for I. tricolor 
and S. tomentosa extracts and drugs. While, MDA achieved significant 
decrease by 112.37, 89.57 and 113.02%, respectively, for I. tricolor and 
S. tomentosa as well as atorvastatin-glibenclamide reference drugs, in 
comparison with normal as well as positive control rats.
Treatment of HC-HG rats with I. tricolor and S. tomentosa extracts 
and standard drugs showed insignificant change in NO as compared 
to untreated rats and normal control group, with percentages of 
amelioration reached to 118.89%, 109.14% and 118.95%, respectively, 
for I. tricolor and S. tomentosa and reference drugs. In agreement with 
the current results, Pavana et al. [52] explained the mode of depressing 
nitrite formation by the competition action of plant extracts Tephrosia 
purpurea with oxygen in the reaction with NO and other nitrogen oxides 
such as NO3, and N2O3. The increased oxidized GSH levels in HC-HG rats 
can be attributed to spontaneous non-enzymatic GSH oxidation as 
suggested by Meister and Anderson [55]. GSH in cholesterol- glucose 
stressed rats decreased significantly (56.36%) as compared to the 
normal ones. These reductions may be due to the increased utilization 
of these anti-oxidants for quenching free radicals produced during 
HC-HG condition. In parallel results, Qi et al. [56] found that atorvastatin 
and glibenclamide treatment to HC-HG rats enhanced the concentration 
of liver GSH and attributed this to the ability of drugs to improve the 
defensive nature of liver against free radicals which in turn preserved 
liver and pancreas architectures. Thus, the same could be applicable 
to I. tricolor and S. tomentosa extracts which in turn ameliorate liver 
and pancreas architectures. Hence, it could be concluded that I. tricolor 
and S. tomentosa showed antihyperlipidemic and anti-HG activities 
which need further clinical research to using as a promising candidate 
nutraceuticals.
The hypolipidemic effect of I. tricolor and S. tomentosa
Data manipulated in Table 4 clearly indicated insignificant difference 
in lipid profile in healthy control rats treated with I. tricolor and 
S. tomentosa extracts as compared to normal control rats. HC-HG rats 
showed significant elevation in TG (183.71%), TC (113.76%), and 
LDL-C (102.46%) while a significant reduction in HDL-C was detected 
(97.39%), comparing to control rats. The oral supplementation 
of I. tricolor extract and reference drug to HC-HG rats resulted in 
insignificant change in TC, HDL-C and TG with amelioration percentages 
127.48%, 131.13% and 181.96%, respectively. Although, LDL-C 
level recorded significant increase with percentage of improvement 
68.13%. In addition, the treatment of diabetic rats with S. tomentosa 
exhibited insignificant change in TC, HDL-C and TG with percentages of 
amelioration 105.60%, 84.90% and 147.27%, respectively, while LDL-C 
demonstrated significant increase with the percentage of improvement 
83.79%. Regarding reference drugs, the percentages of amelioration 
in TC, LDL-C, HDL-C and TG reached to 87.94%, 81.02%, 64.78% and 
188.21%, respectively (Table 4).
Histopathological investigation
Histopathological investigation of liver tissue revealed normal structure 
of hepatic cells and no observed changes in normal rats treated with I. 
Table 3: Comparative effects of I. tricolor and S. tomentosa supplementation on antioxidant markers in control and 
different therapeutic groups
Groups Parameters GSH MDA NO
Negative control Mean±SD 106±4.54b 0.307±0.059c 16.30±0.36cd
Negative treated with I. tricolor Mean±SD 129.25±7.8a 0.345±0.012bc 14.37±0.28d
% Change to control +21.93 +12.37 −11.84
Negative treated with S. tomentosa Mean±SD 131±2.75a 0.367±0.026bc 15.62±0.42d
% Change to control +23.58 +19.54 −4.17
HC-HG Mean±SD 46.25±3.86d 0.697±0.05a 39.57±3.90a
% Change to control −56.36 +127.03 +142.76
HC-HG treated with I. tricolor Mean±SD 87.50±3.78c 0.352±0.040bc 20.19±0.85bc
% Change to control −17.45 +14.65 +23.86
% of improvement 38.91 −112.37 −118.89
HC-HG treated with S. tomentosa Mean±SD 96.75±6.02c 0.422±0.25b 21.78±0.53b
% Change to control −8.72 +37.45 +33.61
% of improvement 47.64 −89.57 −109.14
HC-HG treated with glibenclamide and atorvastatin Mean±SD 92.75±10.04c 0.35±0.026bc 20.18±4.08bc
% Change to control −12.5 −14.00 +23.80
% of improvement 43.86 −113.02 −118.95
GSH is expressed in mmol/L, MDA is expressed in ηmol/mL and NO is expressed in µmol/mL. Data presented as mean±SD, n=10. Statistical analysis is carried out using 
Co-state and SPSS computer programs (version 7), where unshared letter is significant at p≤0.05. SD: Standard deviation, HC-HG: Hypercholesterolemia-Hyperglycemia, 
S. tomentosa: Sophora tomentosa, I. tricolor: Ipomoea tricolor, MDA: Malondialdehyde, GSH: Glutathione, NO: Nitric oxide
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tricolor and S. tomentosa (Fig. 1c and b) as compared to normal untreated 
control rats (Fig. 1a). However, HC-HG rats exhibited congestion in portal 
vessels and sinusoids with mild centrilobular hepatocyte degeneration 
(Fig. 1d), moderate to marked hepatocyte ballooning (black arrow), 
and hydropic degeneration (Fig. 1e). While HC-HG rats treated with 
S. tomentosa showed normal lobular hepatic architecture (Fig. 1f). In 
addition, HC-HG rats treated with I. tricolor declared nearly normal 
hepatic cells with mild sinusoidal dilatation and congestion (Fig. 1g). 
Furthermore, HC-HG rats treated with reference drug exhibited normal 
hepatic architecture with arranged hepatocyte (Fig. 1h). In addition, 
treatment of control rats with I. tricolor and S. tomentosa showed no 
changes in Islets of Langerhans (Fig. 2b and c) as compared to normal 
untreated control rats (Fig. 2a). HC-HG rats showed disarrangement 
changes in pancreatic blood vessels and interlobular duct (Fig. 2d) 
and disordered in acini (exocrine duct) (Fig. 2e). However, pancreatic 
tissue of HC-HG rats treated with I. tricolor and S. tomentosa as well as 
standard drug showed enhancement in Langerhans cells (Fig. 2f-h). An 
image recognition system was built to extract data from these tissues 
photographed liver and pancreas tissues Images [57].
This study shows that the cholesterol-enriched diet for 12-week 
resulted in a dramatic surge in serum total cholesterol (81.83%), total 
lipids (63.74%), and TGs (176.30%). Concerning lipoproteins, it was 
obvious that circulating serum HDL-C level was significantly diminished 
(85.74%) in the cholesterol-stressed rats, whereas atherogenic 
lipoproteins; LDL-C level was significantly raised as compared to normal 
control group, thus providing a model for dietary hyperlipidemia. The 
increase of lipid parameters had been shown to be a strong risk factor 
for coronary heart diseases (CHD) in many populations [51,58]. These 
results run in parallel with Rizk et al. [32,33]. People with higher levels 
of HDL-C seem to protect from coronary vascular diseases as HDL-C act 
as antioxidant and protect LDL-C from oxidation so reduce LDL-C from 
circulation [58].
In diabetic complications, besides the abnormality in glucose 
metabolism, DM often includes another metabolic disorder that is 
abnormality in lipid metabolism [59]. Under normal condition, insulin 
activates lipoprotein lipase (LPL) which hydrolyzes triglycerides. Insulin 
deficiency results in failure to activate the LPL enzyme, thereby causing 
hypertriglyceridemia [60]. On the other hand, in insulin deficient, the 
plasma free fatty acids concentration is elevated as a result of increased 
free fatty acids outflow from fat depots, where the balance of the free 
fatty acids esterification, triglycerides lipolysis is displaced in favor of 
lipolysis [32,33,60]. Moreover, HC and hypertriglyceridemia are often 
associated with DM and this increment may be explained on the basis 
of STZ-induced diabetes; there is excess of fatty acids in the serum, 
which promotes conversion of excess fatty acids into phospholipids 
and cholesterol in the liver. The significant elevation in lipid profile in 
serum of HC-HG rats was achieved also by Hristova and Aloe [61] and 
Borai et al. [2], who attributed hyperlipidemia in DM to elevated level of 
cortisol, which has an important role in the process of fat accumulation 
as cortisol promotes the liberation of free fatty acids from adipose 
tissue into blood stream by inducing and maintaining the synthesis 
of the hormone sensitive lipase, thus increasing free fatty acids level 
which contributes to cardio-vascular risk.
It was noticed that HC-diet raises hepatic cholesterol content resulting in 
the increase of TG synthesis. The cholesterol biosynthesis is controlled 
by the rate limiting enzyme, HMG-CoA reductase. Statin blocks this 
enzyme and thereby prevents cholesterol biosynthesis [51,62]. In this 
study, the cholesterol lowering effects of statin (mainly LDL-C) can be 
attributed to HMG-CoA reductase inhibition.
The present results show 97.39% increase in serum TC level of HC-HG 
rats, which is comparable with that reported by Borai et al. [2], who 
feed rats cholesterol (0.3%) diet with the addition of bile acids (0.5%) 
and showed 1.7-fold higher total cholesterol in their cholesterol-fed 
rats than normal rats. In consistent with this study, Jang et al. [63] 
attributed the effect of HC to the increased dietary cholesterol 
intake that subsequently increased the rate of intestinal cholesterol 
absorption. Furthermore, lard fat is rich in saturated fatty acids, known 
to increase serum LDL-C and monounsaturated fatty acids, which can 
increase serum TG [2].
Moreover, in parallel results Cohen et al. [64], found that cholesterol-
enriched diet resulted in a significant increase in total cholesterol, total 
lipids, phospholipids and TG in serum and liver and these elevated 
parameters were associated with increased serum LDL-c level and 
decreased circulating HDL-C, thus providing a model for dietary 
hyperlipidemia.
The present results demonstrate, significantly increase in LDL-C in 
HC-HG rats, while, significantly lower levels of them were detected in 
I. tricolor and S. tomentosa treated rats. The high level of LDL-C found in 
HC-HG rats may be attributed to a down-regulation in LDL-C receptors 
by cholesterol and saturated fatty acids included in the diet [65]. In 
contrast, reduction in HDL-C (97.39) following cholesterol feeding 
may be due to contributed acceleration of apolipoprotein A-I (apoA-I) 
clearance from the serum based on cholesterol-enriched diets. HDL-C 
binds to arterial and transports it to the liver for metabolisms [30,66].
Table 4: Comparative effects of I. tricolor and S. tomentosa supplementation on lipid profile in control and different therapeutic groups
Groups Parameters TC LDL-C HDL-C TG
Negative control Mean±SD 92.00±2.44b 16.60±1.02d 53.25±6.18c 85.5±3.10b
Negative treated with I. tricolor Mean±SD 87.50±6.45b 16.80±0.22d 47.25±3.20c 79±13.11b
% Change to control −4.89 +1.20 −11.26 −7.60
Negative treated with S. tomentosa Mean±SD 85.75±7.88b 17.33±1.70d 47.91±3.68b 82±3.55b
% Change to control −6.79 +4.39 −10.028 −4.093
HC-HG Mean±SD 196.66±53.28a 33.61±0.89a 22.33±2.30a 242.58±82.19a
% Change to control +113.76 +102.46 −97.39 +183.71
HC-HG treated with I. tricolor Mean±SD 79.37±11.90b 22.30±1.75b 43.50±8.00c 87±25.49b
% Change to control −13.72 +34.96 −18.30 +1.75
% of improvement −127.48 −68.13 −131.13 −181.96
HC-HG treated with S. tomentosa Mean±SD 99.50±7.37b 19.70±1.73c 68.12±8.00c 116.66±36.70b
% Change to control +8.52 +20.85 +27.92 +36.44
% of improvement −105.60 −83.79 −84.90 −147.27
HC-HG treated with glibenclamide and atorvastatin Mean±SD 115.75±18.94b 20.16±1.34c 78.83±9.65b 81.66±6.59b
% Change to control +25.81 +21.44 +48.03 −4.49
% of improvement −87.94 −81.02 −64.78 −188.21
TC, LDL-C, HDL-C and TG are expressed in mg/dL. Data presented as mean±SD, n=10. Statistical analysis is carried out using Co-state and SPSS 
computer programs (version 7), where unshared letter is significant at p≤0.05. SD: Standard deviation, HC-HG: Hypercholesterolemia-Hyperglycemia, 
S. tomentosa: Sophora tomentosa, I. tricolor: Ipomoea tricolor, TC: Total cholesterol, TG: Triacylglycerol, HDL-C: High-density lipoprotein-cholesterol, LDL-C: Low-density 
lipoprotein-cholesterol
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The treatment of cholesterol-stressed rats with I. tricolor and 
S. tomentosa extracts induced marked significant decrease of 
serum total lipids, total cholesterol, TG and LDL-c concentrations 
as compared to the positive control HC-HG rats. Rats treated with 
both extracts showed enhanced HDL-C level (131.13% and 84.90% 
for I. tricolor and S. tomentosa, respectively); which may be due 
to the ability of the extract to hasten the decomposition of free 
radical species generated during cholesterol administration; this 
corroborates the report of a previous study of Aly et al. [67] who 
explained that due to inhibition of lipogenic enzymes as LPL [2]. 
Moreover, this hypolipidemic effect of extracts might be due todietary 
fibers which are known to interfere with cholesterol absorption and 
enter to hepatic bile circulation, resulting in depletion of hepatic 
cholesterol pools and reducing TAG levels by inhibition of hepatic 
lipogenesis [2].
The mechanism, by which extracts reduce serum lipoprotein levels 
in HC-HG rats, may be through the inhibition of 3-hydroxy-3-
methylglutaryl coenzyme A reductase, the rate-limiting enzyme of 
cholesterol biosynthesis [68]. Both extracts produced a significantly 
lower serum TG level, another well-established and recognized risk 
factor for developing atherosclerosis [69]. Thus, the significantly 
lower serum total cholesterol levels produced by the extract indicates 
the ability of the extract to protect against cardiovascular diseases 
(CVDs). In addition, the decreased serum TG concentration in HC-HG 
rats treated with extracts may be explained on the basis of increased 
clearance of TG secondary to increased activity of LPL [70].
The low atherogenic indices are seemed to be protective against 
CHD, and the high HDL-C levels could potential contribute to its anti-
atherogenic properties including its capacity to inhibit LDL-C oxidation 
and protect endothelial cells from the cytotoxic effects of oxidized 
LDL-C [71]; thus, these treatments provides us with a good indicator 
of reducing atherogenicity, which leads in consequence to a decreased 
possibility of CVD occurrence.
Significant reductions of serum TC and LDL-C concentrations and 
elevations of daily bile acid excretion in I. tricolor and S. tomentosa treated 
rats suggested the mechanism of cholesterol breakdown into bile acid, 
by which both-extracts effectively lowered serum cholesterol levels. 
When diet supplemented with I. tricolor and S. tomentosa extracts was 
consumed, other nutritional components were digested and absorbed 
from the small intestine and extracts became a major component in 
the gut lumen. LDL-C was removed from blood and converted into bile 
acids by the liver to replace the bile acids lost in the stool, consequently, 
serum LDL-C was also decreased simultaneously [72]. Furthermore, 
the reductions in lipid levels may be due to the increased fecal lipid 
excretion. Thus, the reduced absorption of cholesterol and fat is an 
important hypolipidemic action of extracts. This result might suggest 
that both extracts can effectively prevent HC-HG and longer treatment 
Fig. 2: (a) Histological organization of the pancreas of control rats ×200. (b) Of pancreas of control rats treated with Ipomoea tricolor and 
Sophora tomentosa showed no change in Islets of Langerhans ×200 stained with H and E. (c) Of the pancreas of control rats treated with 
I. tricolor, (d) No histopathological change. (d) Of pancreas tissue section of hypercholesterolemia-hyperglycemia (HC-HG) rats showing 
disarrangement changes in pancreatic blood vessels and interlobular duct ×200 (H and E). (e) Histological section of the pancreas of 
HC-HG rats revealed disordered in acini (exocrine duct), ×200. (f) Of pancreatic tissue section of HC-HG rats treated with I. tricolor and 
S. tomentosa showed enhancement in Langerhans cells (H and E) ×200. (g) Histological section of the pancreas of HC-HG rats ×200 treated 
with I. tricolor showing restore most of pancreatic histology. (h) Of pancreas tissue section of HC-HG rats treated with standard drug 









Fig. 1: (a) Control liver section, stained with H and E, ×200 showed normal structure of hepatic cells. (b) Liver section of control rats 
treated with Sophora tomentosa showed no observed changes in hepatic cells (H and E, ×200). (c) Of liver section of control rats treated 
with Ipomoea tricolor showed no change in hepatic cells with respect to control group, (d) liver section of hypercholesterolemia-
hyperglycemia (HC-HG) showed congestion in portal vessels and sinusoids with mild centrilobular hepatocyte degeneration stained with 
H and E, ×200. (e) Of liver section of HC-HG rats showed preserved (intact) lobular hepatic architecture, moderate to marked hepatocyte 
ballooning (black arrow), and hydropic degeneration. (f) Demonstrated liver section of HC-HG treated rats with S. tomentosa showed 
normal lobular hepatic architecture (H and E, ×200). (g) Of liver section HC-HG treated with I. tricolor showed nearly normal hepatic cells 
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was better in terms of its HC-HG effect. It is possible the beneficial effects 
of I. tricolor and S. tomentosa extracts may lead to the development of 
nutraceuticals agent. This finding is in agreement with Makni et al. [58], 
who stated that an increase in the HDL-C is one of the most important 
criteria for ananti-HC agent. Furthermore, the anti-hyperlipidemic- HG 
activities of I. tricolor and S. tomentosa extracts may be attributed to 
an important relationship between the anti-hyperlipidemic effect and 
the antioxidant activities of both extracts [73]. Besides, the correction 
of insulin level induced by plants causing a regulation of carbohydrate 
and lipids metabolism by inhibition of lipolysis through inhibition of 
hormone-sensitive lipases activity in adipose tissue and suppresses the 
release of free fatty acids causing stimulation of lipogenesis [74].
CONCLUSION
The present research in bioinformatics focuses on pharmacological 
effects of extract of I. tricolor and S. tomentosa on some biochemical 
parameters in high fat diet-induced HC and STZ-induced HG in rats 
compared to atorvastatin. Repairing effect of I. tricolor and S. tomentosa 
on liver injury and oxidative damage in HC–HG induced rats is clearly 
revealed. Hence, it could be concluded that I. tricolor and S. tomentosa 
exhibited antihyperlipidemic and anti-HG activities with more or less 
similar effect which need more further clinical research to using as 
a promising candidate nutraceuticals. In the future, we need a new 
approach to be applied to the problem of classifying biochemical 
parameters according to pharmacological effects of natural extracts. 
Therefore extracting meaningful, accurate knowledge about this 
problem could provide an insight into the behavior of drugs when 
binding to the recognition of injured tissues that could assist drug 
designers.
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